Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018225784) VACCINE COMPOSITION AND ADJUVANT
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/225784 International Application No.: PCT/JP2018/021695
Publication Date: 13.12.2018 International Filing Date: 06.06.2018
IPC:
A61K 39/00 (2006.01) ,A61K 39/39 (2006.01) ,A61P 37/04 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
39
characterised by the immunostimulating additives, e.g. chemical adjuvants
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
02
Immunomodulators
04
Immunostimulants
Applicants:
株式会社Atomis ATOMIS INC. [JP/JP]; 京都府京都市上京区梶井町448-5 クリエイション・コア京都御車208室 Creation Core Kyoto Mikuruma #208, 448-5 Kajii-cho, Kamigyo-ku, Kyoto-shi Kyoto 6020841, JP
Inventors:
浅利大介 ASARI Daisuke; JP
加藤慎司 KATO Shinji; JP
Agent:
加藤慎司 KATO Shinji; JP
Priority Data:
2017-11211506.06.2017JP
Title (EN) VACCINE COMPOSITION AND ADJUVANT
(FR) COMPOSITION DE VACCIN ET ADJUVANT
(JA) ワクチン組成物及びアジュバント
Abstract:
(EN) The purpose of the present invention is to provide an excellent vaccine composition and adjuvant. The vaccine composition contains an antigen for inducing immunity, and a metal-organic framework. The adjuvant contains a metal-organic framework.
(FR) L’invention a pour objet de fournir une excellente composition de vaccin et un adjuvant. La composition de vaccin de l’invention contient un antigène destiné à induire une immunité, et un réseau de coordination organométallique. L’adjuvant de l’invention contient également un réseau de coordination organométallique.
(JA) 本発明は、優れたワクチン組成物及びアジュバントを提供することを目的とする。本発明に係るワクチン組成物は、免疫誘導のための抗原と、金属有機構造体とを含んでいる。本発明に係るアジュバントは、金属有機構造体を含んでいる。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)